Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Eledon Pharmaceuticals, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 85 | 2 | 83 | 0 |
| Shares | 40.8M | 21.5K | 36.5M | −4.35M (−10.7%) |
| Value | $110.7M | $58.3K | $94.5M | −$16.2M (−14.6%) |
2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wellington Management Group LLP | 1,283,939 | $3.33M | 0.00% |
| Catalio Capital Management, LP | 1,061,132 | $2.75M | 0.51% |
| Kovitz Investment Group Partners, LLC | 732,975 | $1.90M | 0.01% |
| Jane Street Group, LLC | 195,201 | $505.6K | 0.00% |
| Deutsche Bank AG | 64,110 | $166.0K | 0.00% |
| Wolverine Trading, LLC | 59,574 | $151.3K | 0.00% |
| Brighton Jones LLC | 39,355 | $101.9K | 0.00% |
| Rockefeller Capital Management L.P. | 36,666 | $95.0K | 0.00% |
| Manufacturers Life Insurance Company, The | 19,072 | $49.4K | 0.00% |
| Panagora Asset Management Inc | 18,628 | $48.2K | 0.00% |
| Cetera Investment Advisers | 15,377 | $39.8K | 0.00% |
| LPL Financial LLC | 13,650 | $35.4K | 0.00% |
| XTX Topco Ltd | 12,848 | $33.3K | 0.00% |
| Summit Financial, LLC | 11,500 | $29.8K | 0.00% |
| Catalyst Funds Management Pty Ltd | 11,400 | $29.5K | 0.00% |
| Advisor Group Holdings, Inc. | 10,000 | $25.9K | 0.00% |
| Russell Investments Group, Ltd. | 4,854 | $12.6K | 0.00% |
| Redwood Park Advisors LLC | 700 | $1.81K | 0.00% |
| SRS Capital Advisors, Inc. | 152 | $393 | 0.00% |
| The PNC Financial Services Group, Inc. | 9 | $23 | 0.00% |
| CWM, LLC | 88 | $0 | 0.00% |
Sold out (21)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| First Light Asset Management, LLC | 2,600,498 | $7.05M |
| AWM Investment Company, Inc. | 1,100,473 | $2.98M |
| Ikarian Capital, LLC | 1,000,221 | $2.71M |
| Schonfeld Strategic Advisors LLC | 998,454 | $2.71M |
| Alyeska Investment Group, L.P. | 933,475 | $2.53M |
| Boothbay Fund Management, LLC | 293,565 | $795.6K |
| Millennium Management LLC | 171,669 | $465.2K |
| Citadel Advisors LLC | 152,460 | $413.2K |
| Exome Asset Management LLC | 114,145 | $309.3K |
| Marshall Wace, LLP | 94,772 | $256.8K |
| Diadema Partners LP | 64,613 | $175.1K |
| MetLife Investment Management | 36,264 | $98.3K |
| Prelude Capital Management, LLC | 36,141 | $97.9K |
| Pathstone Holdings, LLC | 29,464 | $79.8K |
| Freestone Capital Holdings, LLC | 27,366 | $74.2K |
| ADAR1 Capital Management, LLC | 16,900 | $45.8K |
| Persistent Asset Partners Ltd | 14,855 | $40.3K |
| ProShare Advisors LLC | 12,019 | $32.6K |
| Ground Swell Capital, LLC | 11,597 | $31.4K |
| Ameritas Advisory Services, LLC | 1,000 | $2.71K |
| Raymond James Financial Inc | 600 | $1.63K |
Not filed for Q3 2025 yet (2)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Clarity Capital Partners LLC | 11,500 | $31.2K |
| Congress Wealth Management LLC | 10,000 | $27.1K |